HIV infection induces phenotypic and functional changes to CD8 + T cells defined by the
coordinated upregulation of a series of negative checkpoint receptors that eventually result in T …

IL15, a potent stimulant of CD8 + T cells and natural killer (NK) cells, is a promising cancer
immunotherapeutic. ALT-803 is a complex of an IL15 superagonist mutant and a dimeric IL15 …

Objective Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is
now a global pandemic. Emerging results indicate a dysregulated immune response. Given …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), is now pandemic with nearly three million cases …

Sequestering of latent HIV in follicular helper T cells within B-cell follicles that largely exclude
cytotoxic T cells is a major barrier to cellular immune-based approaches to eradicate HIV. …

Despite the success of antiretroviral therapy (ART) to halt viral replication and slow disease
progression, this treatment is not curative and there remains an urgent need to develop …

MHC-E is a highly conserved nonclassical MHC class Ib molecule that predominantly binds
and presents MHC class Ia leader sequence-derived peptides for NK cell regulation. …

In the absence of a prophylactic vaccine, the use of antiretroviral therapy (ART) as pre-exposure
prophylaxis (PrEP) to prevent HIV acquisition by uninfected individuals is a promising …

CCR5 plays a central role in infectious disease, host defense, and cancer progression,
thereby making it an ideal target for therapeutic development. Notably, CCR5 is the major HIV …

The CCR5-specific antibody Leronlimab is being investigated as a novel immunotherapy that
can suppress HIV replication with minimal side effects. Here we studied the virological and …